Ningbo Menovo Pharmaceutical Co., Ltd.

Simbol: 603538.SS

SHH

14.58

CNY

Tržna cena danes

  • -165.8310

    Razmerje P/E

  • -26.5330

    Razmerje PEG

  • 3.09B

    Kapaciteta MRK

  • 0.01%

    Donos DIV

Ningbo Menovo Pharmaceutical Co., Ltd. (603538-SS) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Ningbo Menovo Pharmaceutical Co., Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011

balance-sheet.row.cash-and-short-term-investments

0724.71009.3793.2
368.8
442.9
369.9
258.6
125.2
99.5
185.1
119.5
64.1
131.9

balance-sheet.row.short-term-investments

0268.6217.4371.4
133.1
100.6
-2.2
-19.4
-3.1
-3.5
-4.4
0
0.4
3.4

balance-sheet.row.net-receivables

0320.7231.5266.2
193.4
206.7
184.4
94.3
66.8
41.5
173.7
55.3
145.1
64.5

balance-sheet.row.inventory

0612.6594.4579.7
454.7
400.2
299
146.4
143.5
163.9
185.7
156.5
156.8
124.7

balance-sheet.row.other-current-assets

050.359.263.4
117.3
86.7
219.7
278.1
11.2
9.6
5.8
7.3
4.8
4.1

balance-sheet.row.total-current-assets

01759.41894.41702.4
1134.1
1136.4
1073.1
777.3
346.7
314.5
550.3
338.5
370.8
325.2

balance-sheet.row.property-plant-equipment-net

01900.31801.91614.7
1145
927.4
738.8
358.7
290.2
260.4
259.6
397.6
343.8
275.4

balance-sheet.row.goodwill

00022.7
22.7
51
51
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0206.2172.5201.7
224.7
183.2
175.4
107.5
108.6
66.6
52.4
95
96.6
95.7

balance-sheet.row.goodwill-and-intangible-assets

0206.2172.5224.4
247.4
234.2
226.4
107.5
108.6
66.6
52.4
95
96.6
95.7

balance-sheet.row.long-term-investments

0315.382.7-51.8
275.4
83.3
166
258.4
189.7
153.2
88.3
8.1
3.4
3.8

balance-sheet.row.tax-assets

042.7123.133.3
45.5
29.5
19.4
2.7
3.5
3.3
3.2
2
3
4.7

balance-sheet.row.other-non-current-assets

0199.6344.8478.5
215.3
203.2
47.4
9.1
16.5
29.8
13.1
23.4
14.1
5.3

balance-sheet.row.total-non-current-assets

02664.12525.12299.1
1928.6
1477.6
1198
736.4
608.6
513.1
416.6
526.2
460.8
384.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

04423.54419.54001.5
3062.7
2614
2271.1
1513.7
955.3
827.6
966.9
864.7
831.6
710

balance-sheet.row.account-payables

0553.7499.3389.1
373
308.9
262.5
154.7
118
118.4
206.3
156.5
143.3
132.7

balance-sheet.row.short-term-debt

0542.8497505
648.9
472.6
427.9
155
67
30
159
164.7
202.4
133

balance-sheet.row.tax-payables

025.572.134.6
7.6
16
9.8
9.4
6.6
6
11
11
9.7
10.7

balance-sheet.row.long-term-debt-total

0759.6705.6755.3
108.5
123.4
107.9
0
0
0
0
0
0
0

Deferred Revenue Non Current

081.570.648.7
24.2
18.5
18.9
5.6
5.6
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

021713.9
2.1
9.9
79.2
1.2
4
5.5
6.9
26.5
6.2
25.7

balance-sheet.row.total-non-current-liabilities

0859.6884876.2
187.9
169.1
151.5
11
10.7
5.1
4.4
0.3
0.4
1.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

015.730.328
26.8
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

02237.82246.22023
1300.2
1045.4
930.9
351.2
224.3
181.8
402.5
377.2
389
331.5

balance-sheet.row.preferred-stock

036.300
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0213.4213.4151.3
149.6
149.7
149.1
120
90
90
90
90
90
90

balance-sheet.row.retained-earnings

01210.61234.3937.4
811.8
668.3
553.1
479.4
434.8
356.6
285.1
212.2
158.1
128.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

075.6101.477.6
33.6
11.1
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0560.4535.9585.2
556.7
535.1
495
516.9
165.3
164.5
160
161.7
175.6
143.8

balance-sheet.row.total-stockholders-equity

02096.320851751.5
1551.7
1364.1
1197.2
1116.3
690.1
611.2
535
463.9
423.7
362.2

balance-sheet.row.total-liabilities-and-stockholders-equity

04423.54419.54001.5
3062.7
2614
2271.1
1513.7
955.3
827.6
966.9
864.7
831.6
710

balance-sheet.row.minority-interest

089.488.3227
210.8
204.4
143
46.2
40.9
34.7
29.3
23.5
18.8
16.3

balance-sheet.row.total-equity

02185.72173.21978.5
1762.5
1568.5
1340.2
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-

Total Investments

0315.3300.1319.6
408.6
183.9
163.8
239
186.6
149.7
83.9
8.1
0.4
3.4

balance-sheet.row.total-debt

01302.51202.61260.4
757.4
596.1
535.9
155
67
30
159
164.7
202.4
133

balance-sheet.row.net-debt

0846.4410.7838.6
521.7
253.8
165.9
-103.5
-58.2
-69.5
-26.1
45.2
138.6
4.5

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Ningbo Menovo Pharmaceutical Co., Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011

cash-flows.row.net-income

0367.6158.1173.1
160.8
105.1
50
85.1
81.8
78.5
69
60.6
69.3

cash-flows.row.depreciation-and-amortization

0101.898.985
63.7
49.9
32.4
32
29.6
25.9
0
0
0

cash-flows.row.deferred-income-tax

0-40.2-2118.4
-7.6
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

024.75.310.9
20.3
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-85.4-62.2-2.8
-100.4
-115.3
-13.1
-16.2
20.2
-42.1
0
0
0

cash-flows.row.account-receivables

0-213.6-50.9-28.2
-17.6
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-183-124.7-83
-113.1
-70.7
-3
14.5
17.8
-28.5
0
0
0

cash-flows.row.account-payables

0351.4134.463.3
37.8
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-40.2-2145.1
-7.6
-44.6
-10.1
-30.6
2.3
-13.6
0
0
0

cash-flows.row.other-non-cash-items

0-91.441.5-32.9
43
7
10.9
16.3
1.9
12.9
-69
-60.6
-69.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-571.6-529.9-311.7
-328.1
-299.6
-86.2
-108.8
-61.6
-46.1
-75.4
-81.7
-159.7

cash-flows.row.acquisitions-net

0487.9-47.10.5
2.7
-45.1
1.3
0
5
0
0
0.9
0.3

cash-flows.row.purchases-of-investments

0-713.9-1640.5-865
-690.8
-773
-600.3
-35
-69.6
-9.1
-29.4
-7.3
-125

cash-flows.row.sales-maturities-of-investments

0902.51562.2693.5
640
789.4
293.2
0
5
0
0
1.9
48.7

cash-flows.row.other-investing-activites

0-54.6523.8
25
2.1
-29.5
27
62.2
43.8
74.7
-45.1
-10

cash-flows.row.net-cash-used-for-investing-activites

050.3-603.3-479
-351.2
-326.2
-421.6
-116.9
-59
-11.5
-30.1
-131.4
-245.7

cash-flows.row.debt-repayment

0-749.5-788.1-802.5
-630.3
-330.3
-137.9
-50
-163
-273.6
-476.4
-350.7
-240.1

cash-flows.row.common-stock-issued

00.10.20.5
0.6
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-0.1-0.2-0.5
-0.6
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-50-13.8-41
-50.8
-39.1
-4.4
-2.6
-1.8
-10
-27.7
-10.7
-10.5

cash-flows.row.other-financing-activites

0621.11385.1981.9
780.1
753.3
613.5
85.5
29.4
267.9
428.5
413
294.9

cash-flows.row.net-cash-used-provided-by-financing-activities

0-178.5583.1138.4
99
384
471.2
32.9
-135.4
-15.7
-75.6
51.6
44.3

cash-flows.row.effect-of-forex-changes-on-cash

014.6-2.3-2
2.4
-1.5
-3.6
3.3
8.3
0
0
0
0

cash-flows.row.net-change-in-cash

0163.4198.2-91
-70
102.8
126.1
36.6
-52.8
48.1
43.4
-41.7
-79.7

cash-flows.row.cash-at-end-of-period

0537373.6174.5
265.5
335.5
232.7
106.6
70
122.7
74.7
31.2
72.9

cash-flows.row.cash-at-beginning-of-period

0373.6175.4265.5
335.5
232.7
106.6
70
122.7
74.7
31.2
72.9
152.7

cash-flows.row.operating-cash-flow

0277220.6251.6
179.8
46.6
80.2
117.2
133.4
75.2
0
0
0

cash-flows.row.capital-expenditure

0-571.6-529.9-311.7
-328.1
-299.6
-86.2
-108.8
-61.6
-46.1
-75.4
-81.7
-159.7

cash-flows.row.free-cash-flow

0-294.7-309.3-60.1
-148.3
-253
-6.1
8.4
71.9
29.1
-75.4
-81.7
-159.7

Vrstica izkaza poslovnega izida

Prihodki Ningbo Menovo Pharmaceutical Co., Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 603538.SS znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011

income-statement-row.row.total-revenue

01216.514571258.1
1193.7
1180.2
849
605.3
578.1
597.2
636.3
501.7
486.6
490.2

income-statement-row.row.cost-of-revenue

0840.9872.8788.9
758.6
727.6
572.5
399.1
361.5
400.5
426.2
329.1
326.2
331.6

income-statement-row.row.gross-profit

0375.6584.2469.2
435.1
452.6
276.5
206.3
216.6
196.7
210.2
172.6
160.4
158.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-10.8116.4110.8
109.9
102.8
-5.8
0.5
11.5
10.3
2.9
5.4
2.2
2

income-statement-row.row.operating-expenses

0291.2341.4281
236
236.2
171.2
131.6
117.6
119.6
109
87.8
80.1
71.4

income-statement-row.row.cost-and-expenses

01132.11214.21069.9
994.5
963.9
743.7
530.7
479.1
520
535.1
416.9
406.3
403

income-statement-row.row.interest-income

05.55.72.2
3
1.6
2.3
3.6
0.7
1.8
1.2
0
0
0

income-statement-row.row.interest-expense

029.127.427.2
26.2
23.4
19.6
4.4
2.7
1.6
8.1
3.1
3.1
3.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-76.4-21.2-7.6
-0.9
-2.5
1.5
-10.3
6.2
23.9
-7
5.1
-3.1
6.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-10.8116.4110.8
109.9
102.8
-5.8
0.5
11.5
10.3
2.9
5.4
2.2
2

income-statement-row.row.total-operating-expenses

0-76.4-21.2-7.6
-0.9
-2.5
1.5
-10.3
6.2
23.9
-7
5.1
-3.1
6.3

income-statement-row.row.interest-expense

029.127.427.2
26.2
23.4
19.6
4.4
2.7
1.6
8.1
3.1
3.1
3.9

income-statement-row.row.depreciation-and-amortization

0118.5128.3124.1
152.3
97.1
49.9
32.4
32
29.6
25.9
-2.8
9.3
-9.4

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

018.7405.3187.9
215.5
189.7
112.6
63.9
98.5
91.5
91.6
84.8
75.2
92.2

income-statement-row.row.income-before-tax

08384.2180.3
214.7
187.2
106.8
64.4
105.2
101
94.2
89.9
77.2
93.5

income-statement-row.row.income-tax-expense

0-8.216.522.2
41.6
26.4
1.7
14.4
20
19.3
15.7
16.3
12.8
14.8

income-statement-row.row.net-income

011.6338.9142.5
156
150.9
96.3
44.7
78.8
77
72.7
69
60.6
69.3

Pogosto zastavljeno vprašanje

Kaj je Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) skupna sredstva?

Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) skupna sredstva so 4423515920.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.319.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.853.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.014.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -0.013.

Kaj je Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 11585592.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 1302458461.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 291175048.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.